Microtome Market by Product (Microtome [Rotary Microtome, Vibrating Microtome, and Others] and Accessories [Blades and Knives, Cooling Clamp, Others]), Technology (Fully Automated, Semi-Automated, and Manual), End-User (Hospital, Diagnostic Clinics, Academic and Research Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing cases of chronic disorders, rise in research and development activities, among others globally.
The microtome market is estimated to grow at a CAGR of 6.43% during the forecast period from 2024 to 2030. The demand for microtomes is primarily being boosted by the increasing cases of chronic disorders such as cancer, cardiovascular diseases including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), among others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2024 to 2030.
The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million by the year 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases. As cancer diagnosis and treatment rely heavily on accurate tissue examination, the rising cancer rates necessitate the widespread use of microtomes to prepare high-quality tissue sections for microscopic analysis. This surge in cancer cases translates into a larger market for microtomes.
According to data provided by the WHO (2024), in 2019 there were 262 million people affected by asthma. Additionally, in 2.02 trillion people were living with Chronic Obstructive Pulmonary Disorder (COPD) with three-quarters of them living in low and middle-income countries. COPD spurts the critical need for advanced diagnostic and treatment options. Microtomes play a vital role in this context by preparing thin tissue sections for histopathological examination. These sections allow the detailed study of lung tissue architecture, inflammation, and pathological changes, thereby boosting its market.
Therefore, all the above-mentioned factors such as the increasing instances of cancers and respiratory disorders are expected to drive the market for microtomes during the given forecast period.
However, the availability of alternative sample preparation technologies, such as cryo-sectioning and laser microdissection could reduce the reliance on traditional microtomes, acting as factors that are expected to limit their end-user base, thus restricting the growth of the microtome market during the forecast period.
In the technology segment of the microtome market, the fully automated category of microtome is estimated to amass a significant revenue share in the microtome market in 2023. This can be attributed to the large patient population associated with various chronic disorders and the presence of a variety of products available to specific this category.
Fully automated microtomes offer several advantages and diverse applications, significantly enhancing the field of histopathology. Their primary benefits is to produce consistent high quality tissue sections with minimal user intervention, ensuring precision and reproducibility. This automation reduces the risk of human error and variability, which is crucial for accurate diagnosis.
In terms of applications, fully automated microtomes are invaluable in cancer diagnostics, where they provide fine tissue sections needed for detailed examination of tumor morphology and margins. They are also extensively used in research settings to study disease mechanisms at the cellular level, contributing to the development of new treatments and therapies. These advanced instruments are employed in various medical fields, including neuropathology, dermatopathology, and cardiovascular pathology, where precise tissue sectioning is critical for studying complex structures and diagnosing conditions.
Additionally, the presence of a huge number of commercially available fully automated systems and the increasing demand for digitalization in tissue diagnostic procedures are some of the crucial factors anticipated to boost the market in the next few years. Some of the key automated products include Microtome A550, Tissue-Tek Genie, and Leica Biosystems HistoCore AUTOCUT 2550.
Therefore, the various advantages and applications provided by fully automated microtomes will contribute to the growth of this category, thereby driving the growth of the overall microtome market during the forecast period.
National Cancer Institute (2024) estimated that 2 million new cases of cancer will be diagnosed in the US by the end of 2024. Furthermore, it is estimated that prostate, lung, and colorectal cancers are expected to represent approximately 48% of all cancer diagnoses in men. For women, the most prevalent cancers are breast, lung, and colorectal, which are expected to account for about 51% of all new cancer diagnoses.
According to Global Cancer Observatory’s updated data (2024), in 2022, the US represented 89.1% of all cancer cases and Canada represented 10.9% of all cancer cases in the North America region. The reliance on microtomes for accurate tissue sectioning in cancer diagnosis and research is paramount. Microtomes are essential for producing high-quality tissue samples for identifying cancer types, understanding disease progression, and tailoring treatment plans. Consequently, the rising instances of cancer catalyze the demand for microtomes hence propelling market growth.
According to the recently updated data provided by the Centres for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. The high incidence of myocardial infarctions necessitates extensive histological examination of cardiac tissues to understand the underlying causes. Microtomes are essential in preparing thin, detailed sections of heart tissue for microscopic analysis, enabling pathologists to examine cellular structures, detect abnormalities, and evaluate the effectiveness of treatment therefore boosting its market growth.
According to the American Lung Association data updated in April 2024, it stated that more than 34 million people were living in the US with chronic lung diseases like asthma and COPD. These disorders underscore the growing need for microtomes in diagnostic pathology because of their ability to produce high-quality lung tissue sections for microscopic analysis which is vital for diagnosing, understanding, and treating these conditions, consequently boosting the market for microtomes.
Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North American microtome market growth during the forecast period from 2024 to 2030.
This product will be delivered within 2 business days.
The microtome market is estimated to grow at a CAGR of 6.43% during the forecast period from 2024 to 2030. The demand for microtomes is primarily being boosted by the increasing cases of chronic disorders such as cancer, cardiovascular diseases including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), among others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2024 to 2030.
Microtome Market Dynamics:
According to data provided by the World Health Organization (WHO) in 2024, the International Agency for Research on Cancer (IARC) stated that 20 million new instances of cancer were registered in 2022 globally. Additionally, as per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer. Next in order of incidence was breast cancer with 2.3 million cases, colon cancer with 1.9 million cases, and stomach cancer with 0.97 million cases globally.The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million by the year 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases. As cancer diagnosis and treatment rely heavily on accurate tissue examination, the rising cancer rates necessitate the widespread use of microtomes to prepare high-quality tissue sections for microscopic analysis. This surge in cancer cases translates into a larger market for microtomes.
According to data provided by the WHO (2024), in 2019 there were 262 million people affected by asthma. Additionally, in 2.02 trillion people were living with Chronic Obstructive Pulmonary Disorder (COPD) with three-quarters of them living in low and middle-income countries. COPD spurts the critical need for advanced diagnostic and treatment options. Microtomes play a vital role in this context by preparing thin tissue sections for histopathological examination. These sections allow the detailed study of lung tissue architecture, inflammation, and pathological changes, thereby boosting its market.
Therefore, all the above-mentioned factors such as the increasing instances of cancers and respiratory disorders are expected to drive the market for microtomes during the given forecast period.
However, the availability of alternative sample preparation technologies, such as cryo-sectioning and laser microdissection could reduce the reliance on traditional microtomes, acting as factors that are expected to limit their end-user base, thus restricting the growth of the microtome market during the forecast period.
Microtome Market Segment Analysis:
Microtome Market by Product (Microtome [Rotary Microtome, Vibrating Microtome, and Others] and Accessories [Blades and Knives, Cooling Clamp, Others]), Technology (Fully Automated, Semi-Automated, and Manual), End-User (Hospital, Diagnostic Clinics, Academic and Research Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)In the technology segment of the microtome market, the fully automated category of microtome is estimated to amass a significant revenue share in the microtome market in 2023. This can be attributed to the large patient population associated with various chronic disorders and the presence of a variety of products available to specific this category.
Fully automated microtomes offer several advantages and diverse applications, significantly enhancing the field of histopathology. Their primary benefits is to produce consistent high quality tissue sections with minimal user intervention, ensuring precision and reproducibility. This automation reduces the risk of human error and variability, which is crucial for accurate diagnosis.
In terms of applications, fully automated microtomes are invaluable in cancer diagnostics, where they provide fine tissue sections needed for detailed examination of tumor morphology and margins. They are also extensively used in research settings to study disease mechanisms at the cellular level, contributing to the development of new treatments and therapies. These advanced instruments are employed in various medical fields, including neuropathology, dermatopathology, and cardiovascular pathology, where precise tissue sectioning is critical for studying complex structures and diagnosing conditions.
Additionally, the presence of a huge number of commercially available fully automated systems and the increasing demand for digitalization in tissue diagnostic procedures are some of the crucial factors anticipated to boost the market in the next few years. Some of the key automated products include Microtome A550, Tissue-Tek Genie, and Leica Biosystems HistoCore AUTOCUT 2550.
Therefore, the various advantages and applications provided by fully automated microtomes will contribute to the growth of this category, thereby driving the growth of the overall microtome market during the forecast period.
North America Is Expected To Dominate The Overall Microtome Market:
North America is expected to account for the highest proportion of the microtome market in 2023, out of all regions. This is owing to the continual increase in cancer cases in the North America region, the growing myocardial infarction cases, and various lung-related disorders including COPD, among others. Moreover, the high-end medical infrastructure paired with readily available high-tech equipment, expanding prospects for sophisticated cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, rise in healthcare spending, presence of a large number of market players in the region are expected to drive the growth of the microtome market in North America.National Cancer Institute (2024) estimated that 2 million new cases of cancer will be diagnosed in the US by the end of 2024. Furthermore, it is estimated that prostate, lung, and colorectal cancers are expected to represent approximately 48% of all cancer diagnoses in men. For women, the most prevalent cancers are breast, lung, and colorectal, which are expected to account for about 51% of all new cancer diagnoses.
According to Global Cancer Observatory’s updated data (2024), in 2022, the US represented 89.1% of all cancer cases and Canada represented 10.9% of all cancer cases in the North America region. The reliance on microtomes for accurate tissue sectioning in cancer diagnosis and research is paramount. Microtomes are essential for producing high-quality tissue samples for identifying cancer types, understanding disease progression, and tailoring treatment plans. Consequently, the rising instances of cancer catalyze the demand for microtomes hence propelling market growth.
According to the recently updated data provided by the Centres for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. The high incidence of myocardial infarctions necessitates extensive histological examination of cardiac tissues to understand the underlying causes. Microtomes are essential in preparing thin, detailed sections of heart tissue for microscopic analysis, enabling pathologists to examine cellular structures, detect abnormalities, and evaluate the effectiveness of treatment therefore boosting its market growth.
According to the American Lung Association data updated in April 2024, it stated that more than 34 million people were living in the US with chronic lung diseases like asthma and COPD. These disorders underscore the growing need for microtomes in diagnostic pathology because of their ability to produce high-quality lung tissue sections for microscopic analysis which is vital for diagnosing, understanding, and treating these conditions, consequently boosting the market for microtomes.
Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North American microtome market growth during the forecast period from 2024 to 2030.
Microtome Market Key Players:
Some of the key market players operating in the Microtome market include Thermo Fisher Scientific Inc, AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co, Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgeräte GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO., LTD, FEATHER Safety Razor Co., Ltd, Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others.Recent Developmental Activities In The Microtome Market:
- In February 2023, Precisionary Instruments launched a brand new line of rotatory microtome and offered 3 models for the same; RF-600: Manual model, RF-800: Semi-automated model, RF-1000: Fully automated model.
Key Takeaways From The Microtome Market Report Study
- Market size analysis for current microtome market size (2023), and market forecast for 6 years (2024 to 2030)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
- Key companies dominating the microtome market
- Various opportunities available for the other competitors in the microtome market space.
- What are the top-performing segments in 2023? How these segments will perform in 2030?
- Which are the top-performing regions and countries in the current microtome market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for microtome market growth in the coming future?
Target Audience Who Can Be Benefited From This Microtome Market Report Study
- Microtome product providers
- Research organizations and consulting companies
- Microtome-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in microtome
- Various end-users who want to know more about the microtome market and the latest technological developments in the microtome market.
Frequently Asked Questions For The Microtome Market:
1. What is microtome?
Microtomes are specialized devices designed to create thin, uniform sections of tissue or other samples, typically ranging from a few micrometers to tens of micrometers in thickness.2. What is the market for microtome?
The microtome market is estimated to grow at a CAGR of 6.43% during the forecast period from 2024 to 2030.3. What are the drivers for the microtome market?
The Microtome market is primarily being boosted by the increasing cases of chronic disorders such as cancer, cardiovascular diseases including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), among others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2024 to 2030.4. Who are the key players operating in the microtome market?
Some of the key market players operating in Microtome include Thermo Fisher Scientific Inc, AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co, Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgeräte GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO.,LTD, FEATHER Safety Razor Co., Ltd, Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others.5. Which region has the highest share in the microtome market?
North America is expected to dominate the overall microtome market during the forecast period from 2024 to 2030. This is owing to the continual increase in cancer cases in the North America region, the growing myocardial infarction cases, and various lung-related disorders including COPD, among others. Moreover, the high-end medical infrastructure paired with readily available high-tech equipment, expanding prospects for sophisticated cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, rise in healthcare spending, and presence of a large number of market players in the region are expected to drive the growth of the microtome market in North America.This product will be delivered within 2 business days.
Table of Contents
1. Microtome Market Report Introduction
2. Microtome Market Executive Summary
4. Regulatory Analysis
5. Microtome Market Key Factors Analysis
6. Microtome Market Porter’s Five Forces Analysis
7. Microtome Market Assessment
8. Microtome Market Company and Product Profiles
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- AGD Biomedicals Pvt. Ltd.
- SLEE medical GmbH
- Diapath S.p.A.
- Leica Biosystems Nussloch GmbH
- Green Leaf Scientific
- MEDITE Medical GmbH
- LLS ROWIAK LaserLabSolutions GmbH
- Amos Scientific PTY. LTD
- RWD Life Science Co
- Sakura Finetek
- Boeckeler Instruments, Inc.
- HACKER Instruments & Industries Inc.
- microTec Laborgeräte GmbH
- Bright Instrument Co Limited
- JINHUA YIDI MEDICAL APPLIANCES CO.,LTD
- FEATHER Safety Razor Co., Ltd
- Precisionary Instruments
- Powered Milestone Srl
- Weinkauf Medizintechnik
